Latest
US stocks set for mixed open as oil nears $100 and rate-hike odds rise
Dow seen 0.8% lower at 53,013 and Nasdaq 100 0.1% higher at 29,568, while Brent tops $98 and ECB and US rate-hike expectations weigh on sentiment.
Black Wednesday: The Day a Single Trade Made Billions
On September 16, 1992 — a date now permanently known as "Black Wednesday" — the UK government was forced to withdraw the pound sterling from the European Exchange Rate Mechanism after a wave of currency speculation made…
Wall Street Opens Lower as Oil Surge Weighs; Nasdaq Edges Up on AI Stocks
Dow fell ~1% to 52,885 and S&P 500 dropped 0.4% to 7,690 on rising oil prices ahead of an ECB rate move; Nasdaq 100 gained 0.1% to 29,578 as AI-related shares offset weakness.
DAX Flat as Oil Hits $100; Fresenius, Kion Lead Gains
The DAX stalled near 26,007 as Brent approached $100 a barrel on Middle East supply fears. Fresenius and Kion led gains while Infineon fell 4% on a Morgan Stanley downgrade.
Best-Performing Dividend ETFs Over the Past Decade: US and Swiss Comparisons
YCharts ranks three US dividend ETFs among the top performers of the past decade, while Swiss-listed funds from UBS and BlackRock offer lower-cost alternatives with concentrated SMI exposure.
European Stocks Close Mixed; Novartis Slump Drag on Swiss SMI
The EuroStoxx 50 edged higher while the Swiss SMI fell 1.55% weighed down by Novartis, as investors waited on the ECB rate decision and Brent crude neared $100 a barrel.
European stocks little changed ahead of ECB and US inflation data
EuroStoxx 50 rose 0.17% to 6,403.99 as investors awaited Thursday's ECB decision and Friday's US inflation print, while oil shares gained on Gulf tensions.
SMI closes at session low as Novartis posts biggest daily loss ever
The Swiss benchmark fell 1.55% to 14,047, dragged by Novartis (-10.9%) after a Phase III study failure. UBS rose to a 19-year high above 45 francs.
Nestlé says growth reset gains pace as RIG improves to 1.8% in Q2
Nestlé CFO Anna Manz said real internal growth accelerated from 1.2% in Q1 to 1.8% in Q2, with H1 cost savings of CHF 600 million and UTOP margins expected above 17%.
US stocks fall as oil nears $100; Novartis posts steep loss
US indices slipped on higher oil prices and rate-hike concerns, while Novartis fell 9.8% after another trial disappointment and the SMI stayed near its low.
Novartis plunges as oil and rate worries push US and Swiss stocks lower
Novartis fell more than 9% after a phase-III miss, dragging the SMI lower as US stocks slipped on rising oil prices and rate-hike expectations.
US Markets Slide as Oil Hits $98; Novartis Plunges Toward Record Loss
Brent crude climbs toward $100 on Middle East tensions, weighing on Wall Street and Switzerland's SMI. Novartis falls nearly 10% after Phase III trial miss, wiping out roughly CHF 24 billion in market value.
US Markets Mixed After Holiday; Oil Weighs on Sentiment as Novartis Plunges
Dow futures sink 0.8% as Brent crude approaches $100; Novartis shares tumble over 9% after second clinical miss hits Swiss index.
Confidence Prevails at Structured Products Forum in Interlaken
The International Structured Products Forum in Interlaken saw an optimistic tone driven by strong market performance, while speakers addressed regulatory challenges in Switzerland and the EU.
Dax slips as Brent crude nears $100 and oil prices pressure German stocks
The Dax fell to 25,975 in early afternoon trade as Brent crude approached $100 and WTI and European gas prices rose, while stock-specific ratings drove moves in Dax and MDax names.
US Stocks Expected to Open Mixed After Holiday; Oil Prices Pressuring Sentiment; SMI Continues Decline; Novartis Targets Record Daily Loss
US stock indices show slight movements before market open; oil prices rise, fueling concerns over rising interest rates; Swiss Market Index (SMI) continues to fall; Novartis shares plunge, potentially setting a record daily loss.
Elmet to expand EU refractory metals footprint with German tungsten assets
Elmet Group’s acquisition of ams OSRAM’s tungsten and molybdenum operations in Schwabmünchen, Germany, expands its critical materials capabilities and marks its first EU manufacturing presence.
European Gas At 3-Year Highs: Winners and Losers in the Energy Crunch
Rising gas and fuel prices reshape European equity markets, boosting energy and shipping while weighing on industrials and automakers.
Novartis trial miss drags Swiss SMI lower; Nestlé, Ascom gain
Novartis shares fell nearly 10% after Del-desiran missed a Phase III endpoint, pulling the SMI lower while Nestlé, Sandoz and Ascom gained and Brent approached $100.
European stocks flat; Novartis plunge weighs on Switzerland's SMI
Markets held steady as high energy prices and inflation fears kept investors cautious, while a failed drug trial sent Novartis shares tumbling nearly 9%, dragging the Swiss SMI down more than 1%.
European Stocks Stay Flat; Novartis Study Flop Weighs on Swiss SMI
EuroStoxx 50 flat as high oil and gas prices persist. The Swiss SMI drops 1.18% while Novartis shares fall over 9% after a failed drug trial sinks the stock.
Novartis Plunges After Failed Muscle-Disease Trial; SMI Slides 1.3%
Novartis tumbled nearly 10% after its del-desiran candidate missed a Phase III primary endpoint, erasing roughly CHF 24 billion in market value and pulling the SMI lower. Nestlé and Roche helped stem the damage.
NS Partners moves Zurich office to historic White Castle
The independent asset manager shifted its Zurich branch to a 220‑sqm space in the White Castle owned by Zurich Insurance, citing client service and staff motivation.
Akara Swiss Diversity Property Fund posts stable H1 2026, completes CHF 215m capital increase
The Swiss property fund reported a 2.56% H1 return, lifted rental income by over 9% to CHF 54m and reduced its leverage ratio to 20.73% after an oversubscribed CHF 215m issuance.